共 51 条
[1]
Morgan DJ(1995)Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update Clin Pharmacokinet 29 370-391
[2]
McLean AJ(1999)Effects of liver disease on pharmacokinetics. An update Clin Pharmacokinet 37 399-431
[3]
Rodighiero V(1995)Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease Hepatology 21 120-128
[4]
George J(1977)Protein binding and kinetics of drugs in liver diseases Clin Pharmacokinet 2 32-44
[5]
Murray M(1978)Diseases and drug protein binding Clin Pharmacokinet 3 144-154
[6]
Byth K(1982)Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds Eur J Rheumatol Inflamm 5 87-92
[7]
Farrell GC(1999)Dosing recommendations in liver disease Clin Pharmacol Ther 66 201-204
[8]
Blaschke TF(2000)Pharmacokinetic effects of celecoxib, a selective cyclooxygenase 2 inhibitor (COX-2), in alcoholic cirrhosis and healthy subjects Clin Pharmacol Ther 67 164-242
[9]
Tillement JP(2000)Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor Clin Pharmacokinet 38 225-1148
[10]
Lhoste F(2000)Rofecoxib steady-state pharmacokinetics in moderate hepatic insufficiency patients Am J Gastroenterol 95 2519-undefined